Canada Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, MRI), By Route Of Administration (Oral Route, Intravenous), By Product, By Application, By End-use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within Immediate
Canada Contrast Media Market Trends
The Canada contrast media market size was estimated at USD 187.60 million in 2023 and is projected t%li%grow at a CAGR of 7.2% from 2024 t%li%2030. Contrast media are agents used in medical imaging t%li%enhance the visibility of internal body structures. They are crucial in diagnostic procedures such as X-rays, CT scans, MRIs, and ultrasounds. In Canada, the market for these substances is driven by increasing demand for advanced diagnostic imaging, the rising prevalence of chronic diseases, and a growing aging population.
According t%li%the Canadian Cancer Society's 2024 report, researchers anticipated 88,100 cancer-related deaths and 247,100 new cancer cases in Canada for 2024. They projected that each day in 2024, approximately 675 Canadians would be diagnosed with cancer, and 241 Canadians would succumb t%li%the disease. Technological advancements in imaging techniques and introducing novel contrast agents further propel the market. In addition, government initiatives aimed at improving healthcare infrastructure and accessibility contribute significantly t%li%market expansion. With healthcare facilities increasingly adopting advanced imaging modalities, the demand for contrast media is set t%li%rise steadily, ensuring robust market growth over the coming years.
Technological advancements play a pivotal role in the market growth. Developing new contrast agents that are more effective and safer for patients is a significant driver. For instance, the advent of microbubble contrast agents has enhanced ultrasound imaging, while gadolinium-based agents have improved MRI diagnostics. These innovations facilitate better image clarity and diagnostic accuracy, critical in early disease detection and treatment planning.
Furthermore, advancements in imaging technology, such as high-resolution and 3D imaging, require high-quality contrast media t%li%achieve optimal results. For instance, in March 2024, Applied Pharmaceutical Innovation (API) and Voyageur Pharmaceuticals Ltd. entered int%li%a Master Services Agreement (MSA). This collaboration is poised t%li%significantly boost both organizations' dedication t%li%innovation and bolster Canada's life sciences sector. The strategic partnership aims t%li%expedite Voyageur's imaging contrast medium's development, production, and commercialization. Integrating artificial intelligence (AI) in imaging processes als%li%supports advanced contrast media, enabling more precise and efficient diagnoses. As technology evolves, the Canadian market will likely see the introduction of even more sophisticated contrast agents, further driving market growth.
In addition, government initiatives and healthcare policies significantly impact the market in Canada. The Canadian government has been actively investing in the healthcare sector t%li%enhance the quality and accessibility of medical services. Policies t%li%reduce diagnostic wait times and improve patient outcomes directly influence the demand for advanced imaging modalities and contrast media. Programs such as the Canadian Institutes of Health Research (CIHR) funding and provincial healthcare funding initiatives support the adoption of cutting-edge medical technologies, including advanced contrast agents.
Furthermore, regulatory frameworks ensure the safety and efficacy of contrast media, promoting trust and widespread use among healthcare professionals. As the government continues prioritizing healthcare improvements and technological advancements, the market is expected t%li%benefit from increased investment and supportive policies. For instance, in January 2023, Bayer AG announced that its iodine-based contrast agents, Ultravist-300 and Ultravist-370, were approved for contrast-enhanced mammography (CEM) in the European Union. Regulatory agencies worldwide are establishing guidelines t%li%ensure Canada's contrast media therapies' safety, efficacy, and ethical use. Streamlined approval processes and clearer regulatory pathways encourage commercialization and market expansion investment, facilitating patient access t%li%advanced treatment options.
Canada Contrast Media Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the Canada contrast media market report based on modality, product, route of administration, application, and end use:
Canada Contrast Media Market Trends
The Canada contrast media market size was estimated at USD 187.60 million in 2023 and is projected t%li%grow at a CAGR of 7.2% from 2024 t%li%2030. Contrast media are agents used in medical imaging t%li%enhance the visibility of internal body structures. They are crucial in diagnostic procedures such as X-rays, CT scans, MRIs, and ultrasounds. In Canada, the market for these substances is driven by increasing demand for advanced diagnostic imaging, the rising prevalence of chronic diseases, and a growing aging population.
According t%li%the Canadian Cancer Society's 2024 report, researchers anticipated 88,100 cancer-related deaths and 247,100 new cancer cases in Canada for 2024. They projected that each day in 2024, approximately 675 Canadians would be diagnosed with cancer, and 241 Canadians would succumb t%li%the disease. Technological advancements in imaging techniques and introducing novel contrast agents further propel the market. In addition, government initiatives aimed at improving healthcare infrastructure and accessibility contribute significantly t%li%market expansion. With healthcare facilities increasingly adopting advanced imaging modalities, the demand for contrast media is set t%li%rise steadily, ensuring robust market growth over the coming years.
Technological advancements play a pivotal role in the market growth. Developing new contrast agents that are more effective and safer for patients is a significant driver. For instance, the advent of microbubble contrast agents has enhanced ultrasound imaging, while gadolinium-based agents have improved MRI diagnostics. These innovations facilitate better image clarity and diagnostic accuracy, critical in early disease detection and treatment planning.
Furthermore, advancements in imaging technology, such as high-resolution and 3D imaging, require high-quality contrast media t%li%achieve optimal results. For instance, in March 2024, Applied Pharmaceutical Innovation (API) and Voyageur Pharmaceuticals Ltd. entered int%li%a Master Services Agreement (MSA). This collaboration is poised t%li%significantly boost both organizations' dedication t%li%innovation and bolster Canada's life sciences sector. The strategic partnership aims t%li%expedite Voyageur's imaging contrast medium's development, production, and commercialization. Integrating artificial intelligence (AI) in imaging processes als%li%supports advanced contrast media, enabling more precise and efficient diagnoses. As technology evolves, the Canadian market will likely see the introduction of even more sophisticated contrast agents, further driving market growth.
In addition, government initiatives and healthcare policies significantly impact the market in Canada. The Canadian government has been actively investing in the healthcare sector t%li%enhance the quality and accessibility of medical services. Policies t%li%reduce diagnostic wait times and improve patient outcomes directly influence the demand for advanced imaging modalities and contrast media. Programs such as the Canadian Institutes of Health Research (CIHR) funding and provincial healthcare funding initiatives support the adoption of cutting-edge medical technologies, including advanced contrast agents.
Furthermore, regulatory frameworks ensure the safety and efficacy of contrast media, promoting trust and widespread use among healthcare professionals. As the government continues prioritizing healthcare improvements and technological advancements, the market is expected t%li%benefit from increased investment and supportive policies. For instance, in January 2023, Bayer AG announced that its iodine-based contrast agents, Ultravist-300 and Ultravist-370, were approved for contrast-enhanced mammography (CEM) in the European Union. Regulatory agencies worldwide are establishing guidelines t%li%ensure Canada's contrast media therapies' safety, efficacy, and ethical use. Streamlined approval processes and clearer regulatory pathways encourage commercialization and market expansion investment, facilitating patient access t%li%advanced treatment options.
Canada Contrast Media Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the Canada contrast media market report based on modality, product, route of administration, application, and end use:
- Modality Outlook (Revenue, USD Million, 2018 - 2030)
- Ultrasound
- Magnetic Resonance Imaging
- X-ray/Computed Tomography
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Microbubble
- Gadolinium-Based
- Iodinated
- Iodixanol
- Iohexol
- Iopamidol
- Others
- Barium-Based
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Cancer
- Nephrological Disorders
- Musculoskeletal Disorders
- Others
- Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intravenous
- Oral Route
- Rectal Route
- End Use Outlook (Revenue, USD Million, 2018 - 2030¬)
- Hospitals
- Private Clinics
- Others
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Product
1.2.3. Route of Administration
1.2.4. Application
1.2.5. End Use
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Product outlook
2.2.3. Route of Administration outlook
2.2.4. Application outlook
2.2.5. End Use outlook
2.3. Competitive Insights
CHAPTER 3. CANADA CONTRAST MEDIA MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Canada Contrast Media Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. CANADA CONTRAST MEDIA MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Canada Contrast Media Market: Modality Movement Analysis
4.3. Canada Contrast Media Market by Modality Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Ultrasound
4.5.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Magnetic Resonance Imaging
4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. X-ray/Computed Tomography
4.7.1. X-ray/Computed Tomography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. CANADA CONTRAST MEDIA MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Canada Contrast Media Market: Product Movement Analysis
5.3. Canada Contrast Media Market by Product Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Microbubble
5.5.1. Microbubble Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Gadolinium-Based
5.6.1. Gadolinium-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Iodinated
5.7.1. Iodinated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. Iodixanol
5.7.2.1. Iodixanol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3. Iohexol
5.7.3.1. Iohexol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3.2. Iopamidol
5.7.3.2.1. Iopamidol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3.3. Others
5.7.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Barium-Based
5.8.1. Barium-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. CANADA CONTRAST MEDIA MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Canada Contrast Media Market: Application Movement Analysis
6.3. Canada Contrast Media Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Cardiovascular Disorders
6.5.1. Cardiovascular Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Neurological Disorders
6.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Gastrointestinal Disorders
6.7.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Cancer
6.8.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Nephrological Disorders
6.9.1. Nephrological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Musculoskeletal Disorders
6.10.1. Musculoskeletal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. CANADA CONTRAST MEDIA MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Canada Contrast Media Market: Route of Administration Movement Analysis
7.3. Canada Contrast Media Market by Route of Administration Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Intravenous
7.5.1. Intravenous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Oral Route
7.6.1. Oral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Rectal Route
7.7.1. Rectal Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. CANADA CONTRAST MEDIA MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Canada Contrast Media Market: End Use Movement Analysis
8.3. Canada Contrast Media Market by End Use Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Hospitals
8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Private Clinics
8.6.1. Private Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Others
8.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. Voyageur Pharmaceuticals, Ltd
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Bayer AG
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Bracco
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. GE HealthCare
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Guerbet
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Lantheus Medical Imaging, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Grupo Juste
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Product
1.2.3. Route of Administration
1.2.4. Application
1.2.5. End Use
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Product outlook
2.2.3. Route of Administration outlook
2.2.4. Application outlook
2.2.5. End Use outlook
2.3. Competitive Insights
CHAPTER 3. CANADA CONTRAST MEDIA MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Canada Contrast Media Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. CANADA CONTRAST MEDIA MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Canada Contrast Media Market: Modality Movement Analysis
4.3. Canada Contrast Media Market by Modality Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Ultrasound
4.5.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Magnetic Resonance Imaging
4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. X-ray/Computed Tomography
4.7.1. X-ray/Computed Tomography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. CANADA CONTRAST MEDIA MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Canada Contrast Media Market: Product Movement Analysis
5.3. Canada Contrast Media Market by Product Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Microbubble
5.5.1. Microbubble Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Gadolinium-Based
5.6.1. Gadolinium-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Iodinated
5.7.1. Iodinated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. Iodixanol
5.7.2.1. Iodixanol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3. Iohexol
5.7.3.1. Iohexol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3.2. Iopamidol
5.7.3.2.1. Iopamidol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3.3. Others
5.7.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Barium-Based
5.8.1. Barium-Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. CANADA CONTRAST MEDIA MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Canada Contrast Media Market: Application Movement Analysis
6.3. Canada Contrast Media Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Cardiovascular Disorders
6.5.1. Cardiovascular Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Neurological Disorders
6.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Gastrointestinal Disorders
6.7.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Cancer
6.8.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Nephrological Disorders
6.9.1. Nephrological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Musculoskeletal Disorders
6.10.1. Musculoskeletal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. CANADA CONTRAST MEDIA MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Canada Contrast Media Market: Route of Administration Movement Analysis
7.3. Canada Contrast Media Market by Route of Administration Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Intravenous
7.5.1. Intravenous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Oral Route
7.6.1. Oral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Rectal Route
7.7.1. Rectal Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. CANADA CONTRAST MEDIA MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Canada Contrast Media Market: End Use Movement Analysis
8.3. Canada Contrast Media Market by End Use Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Hospitals
8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Private Clinics
8.6.1. Private Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Others
8.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. Voyageur Pharmaceuticals, Ltd
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Bayer AG
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Bracco
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. GE HealthCare
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Guerbet
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Lantheus Medical Imaging, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Grupo Juste
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Canada contrast media market, by modality, 2018 - 2030 (USD Million)
Table 4 Canada contrast media market, by product, 2018 - 2030 (USD Million)
Table 5 Canada contrast media market, by route of administration, 2018 - 2030 (USD Million)
Table 6 Canada contrast media market, by application, 2018 - 2030 (USD Million)
Table 7 Canada contrast media market, by end use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Canada contrast media market, by modality, 2018 - 2030 (USD Million)
Table 4 Canada contrast media market, by product, 2018 - 2030 (USD Million)
Table 5 Canada contrast media market, by route of administration, 2018 - 2030 (USD Million)
Table 6 Canada contrast media market, by application, 2018 - 2030 (USD Million)
Table 7 Canada contrast media market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig 1. Adult stem cells market segmentation
Fig 2. Data analysis models
Fig 3. Market formulation and validation
Fig 4. Data validating & publishing
Fig 5. Market research process
Fig 6. Information procurement
Fig 7. Primary research
Fig 8. Value-chain-based sizing & forecasting
Fig 9. QFD modelling for market share assessment
Fig 10. Market formulation & validation
Fig 11. Commodity flow analysis
Fig 12. Market outlook
Fig 13. Segment snapshot-1
Fig 14. Segment snapshot-2
Fig 15. Competitive landscape snapshot
Fig 16. Market trends & outlook
Fig 17. Porter’s five force analysis
Fig 18. PESTEL analysis
Fig 19. Adult stem cells market, type outlook key takeaways (USD Million)
Fig 20. Adult stem cells market: type movement analysis (USD Million), 2023 & 2030
Fig 21. Autologous adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 22. Allogeneic adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 23. Adult stem cells market, product & services outlook key takeaways (USD Million)
Fig 24. Adult stem cells market: product & services movement analysis (USD Million), 2023 & 2030
Fig 25. Product market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 26. Kits, media, & reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 27. Cells & cell lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 28. Hematopoietic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 29. Mesenchymal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 30. Neural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 31. Epithelial/Skin market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 32. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 33. Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 34. Adult stem cells market, indication outlook key takeaways (USD Million)
Fig 35. Adult stem cells market: indication movement analysis (USD Million), 2023 & 2030
Fig 36. Bone and cartilage repair market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 37. Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 38. Inflammatory and immunological diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 39. Liver diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 40. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 41. GvHD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 42. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 43. Adult stem cells market, application outlook key takeaways (USD Million)
Fig 44. Adult stem cells market: application movement analysis (USD Million), 2023 & 2030
Fig 45. Therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 46. Disease modeling market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 47. Drug development & discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 48. Toxicology studies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 49. Biobanking market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 50. Tissue engineering market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 51. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 52. Adult stem cells market, end use outlook key takeaways (USD Million)
Fig 53. Adult stem cells market: end use movement analysis (USD Million), 2023 & 2030
Fig 54. Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 55. Research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 56. Biopharmaceutical companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 57. Adult stem cells market: regional key takeaways (USD Million)
Fig 58. Adult stem cells market: regional outlook, 2023 & 2030, USD billion
Fig 59. North America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 60. U.S. adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 61. Canada adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 62. Mexico adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 63. Europe adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 64. UK adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 65. Germany adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 66. France adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 67. Spain adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 68. Italy adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 69. Norway adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 70. Denmark adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 71. Sweden adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 72. Asia Pacific adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 73. China adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 74. Japan adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 75. India adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 76. South Korea adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 77. Australia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 78. Thailand adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 79. Latin America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 80. Brazil adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 81. Argentina adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 82. Middle East and Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 83. South Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 84. Saudi Arabia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 85. UAE adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 86. Kuwait adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 87. List of key emerging company’s/technology disruptors/innovators
Fig 1. Adult stem cells market segmentation
Fig 2. Data analysis models
Fig 3. Market formulation and validation
Fig 4. Data validating & publishing
Fig 5. Market research process
Fig 6. Information procurement
Fig 7. Primary research
Fig 8. Value-chain-based sizing & forecasting
Fig 9. QFD modelling for market share assessment
Fig 10. Market formulation & validation
Fig 11. Commodity flow analysis
Fig 12. Market outlook
Fig 13. Segment snapshot-1
Fig 14. Segment snapshot-2
Fig 15. Competitive landscape snapshot
Fig 16. Market trends & outlook
Fig 17. Porter’s five force analysis
Fig 18. PESTEL analysis
Fig 19. Adult stem cells market, type outlook key takeaways (USD Million)
Fig 20. Adult stem cells market: type movement analysis (USD Million), 2023 & 2030
Fig 21. Autologous adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 22. Allogeneic adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 23. Adult stem cells market, product & services outlook key takeaways (USD Million)
Fig 24. Adult stem cells market: product & services movement analysis (USD Million), 2023 & 2030
Fig 25. Product market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 26. Kits, media, & reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 27. Cells & cell lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 28. Hematopoietic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 29. Mesenchymal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 30. Neural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 31. Epithelial/Skin market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 32. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 33. Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 34. Adult stem cells market, indication outlook key takeaways (USD Million)
Fig 35. Adult stem cells market: indication movement analysis (USD Million), 2023 & 2030
Fig 36. Bone and cartilage repair market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 37. Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 38. Inflammatory and immunological diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 39. Liver diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 40. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 41. GvHD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 42. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 43. Adult stem cells market, application outlook key takeaways (USD Million)
Fig 44. Adult stem cells market: application movement analysis (USD Million), 2023 & 2030
Fig 45. Therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 46. Disease modeling market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 47. Drug development & discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 48. Toxicology studies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 49. Biobanking market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 50. Tissue engineering market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 51. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 52. Adult stem cells market, end use outlook key takeaways (USD Million)
Fig 53. Adult stem cells market: end use movement analysis (USD Million), 2023 & 2030
Fig 54. Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 55. Research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 56. Biopharmaceutical companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 57. Adult stem cells market: regional key takeaways (USD Million)
Fig 58. Adult stem cells market: regional outlook, 2023 & 2030, USD billion
Fig 59. North America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 60. U.S. adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 61. Canada adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 62. Mexico adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 63. Europe adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 64. UK adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 65. Germany adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 66. France adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 67. Spain adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 68. Italy adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 69. Norway adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 70. Denmark adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 71. Sweden adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 72. Asia Pacific adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 73. China adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 74. Japan adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 75. India adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 76. South Korea adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 77. Australia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 78. Thailand adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 79. Latin America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 80. Brazil adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 81. Argentina adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 82. Middle East and Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 83. South Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 84. Saudi Arabia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 85. UAE adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 86. Kuwait adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 87. List of key emerging company’s/technology disruptors/innovators
